Globus Medical Schedules Second Quarter Earnings Release and Conference Call
Globus Medical (NYSE:GMED), a leading musculoskeletal technology company, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.
The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results with investors. Participants can join via webcast through the company's investor relations website or by telephone through pre-registration. The audio recording will be available after the call on the company's investor website.
Globus Medical (NYSE:GMED), un'azienda leader nel settore della tecnologia muscoloscheletrica, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per giovedì 7 agosto 2025, dopo la chiusura del mercato.
L'azienda terrà una conference call alle 16:30 ora della costa orientale per discutere i risultati con gli investitori. I partecipanti potranno collegarsi tramite webcast sul sito web delle relazioni con gli investitori della società o telefonicamente previa registrazione. La registrazione audio sarà disponibile dopo la chiamata sul sito web degli investitori dell'azienda.
Globus Medical (NYSE:GMED), una empresa líder en tecnología musculoesquelética, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el jueves 7 de agosto de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 4:30 p.m., hora del Este para discutir los resultados con los inversionistas. Los participantes podrán unirse a través de una transmisión web en el sitio de relaciones con inversionistas de la empresa o por teléfono mediante preinscripción. La grabación de audio estará disponible después de la llamada en el sitio web de inversionistas de la compañía.
Globus Medical (NYSE:GMED)는 근골격계 기술 분야의 선도 기업으로, 2025년 2분기 재무실적 발표를 2025년 8월 7일 목요일 시장 마감 후에 예정하고 있습니다.
회사는 투자자들과 결과를 논의하기 위해 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 개최할 예정입니다. 참가자들은 회사 투자자 관계 웹사이트를 통한 웹캐스트 또는 사전 등록을 통한 전화로 참여할 수 있습니다. 통화 후 오디오 녹음은 회사 투자자 웹사이트에서 제공됩니다.
Globus Medical (NYSE:GMED), une entreprise leader dans la technologie musculosquelettique, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le jeudi 7 août 2025, après la clôture du marché.
La société organisera une conférence téléphonique à 16h30, heure de l'Est pour discuter des résultats avec les investisseurs. Les participants pourront rejoindre la réunion via un webcast sur le site des relations investisseurs de la société ou par téléphone après une préinscription. L'enregistrement audio sera disponible après l'appel sur le site des investisseurs de l'entreprise.
Globus Medical (NYSE:GMED), ein führendes Unternehmen im Bereich muskuloskelettaler Technologien, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für Donnerstag, den 7. August 2025, nach Börsenschluss, geplant.
Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse mit Investoren zu besprechen. Teilnehmer können über einen Webcast auf der Investor-Relations-Website des Unternehmens oder telefonisch nach vorheriger Anmeldung teilnehmen. Die Audioaufnahme wird nach dem Anruf auf der Investorenseite des Unternehmens verfügbar sein.
- None.
- None.
AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Thursday, August 7, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
The audio archive will be available after the call on the Investors page of the Globus Medical website.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and achieve anticipated synergies with the integration, health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure of Globus contained in our most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time, and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contacts:
Investors:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
(610) 930-1800
investors@globusmedical.com
www.globusmedical.com
Media:
Moran Chavez
Senior Director, Corporate Affairs
(619) 318-7681
media@globusmedical.com
FAQ
When will Globus Medical (GMED) release Q2 2025 earnings?
How can investors join Globus Medical's Q2 2025 earnings call?
What time is Globus Medical's Q2 2025 earnings conference call?
Where can I find Globus Medical's Q2 2025 earnings release?
